Quantifying AAV viral titers: an examination of qPCR and dPCR technologies across applications

Nucleic acid quantification plays a vital role in therapeutic manufacturing by helping ensure product quality and consistency with quality standards.  In this webinar, Kimberly Gomez and MinGin Kim draw on their combined 20+ years of R&D experience to demonstrate how dPCR and qPCR are used for accurate quantification of both AAV particles and plasmids.

For Research Use Only. Not for use in diagnostic procedures.

What will you learn?Who may this interest?Speakers

In this webinar, you will:

  • Learn how our assay design for AAV ITR2 helps increase workflow efficiency
  • See how dPCR and qPCR can be leveraged to consistently produce highly sensitive and accurate quantification data
  • Understand the benefits and use cases for dPCR and qPCR technologies based on experimental needs
  • Have an opportunity to interact directly with Kimberly and MinGin as a part of a live Q&A session

Bioanalytical scientists studying viral vectors in:

  • Gene therapy
  • Vaccines
  • Regenerative medicines
  • Drug delivery with viral vectors
  • Quality control using qPCR & dPCR

Speakers

        MinGin Kim

Scientist III, Molecular Biology

Genetic Sciences Group, Thermo Fisher Scientific

MinGin joined Thermo Fisher Scientific (MA, USA) to continue pursuing advances in science and engineering technology after obtaining her PhD in medical science from Texas A&M University (TX, USA). She focuses on developing multiplex assays for the Absolute Q digital PCR system while also working on systems projects to further improve the instrument and consumables. Her doctorate studies focused on developing an affordable microfluidic PCR platform for point-of-care analysis based on convection.

 

     Kimberly A. Gomez

Scientist III, Molecular Biology

Genetic Sciences Group, Thermo Fisher Scientific

Kimberly Gomez is a scientist at Thermo Fisher Scientific (MA, USA) specializing in the development and release of dPCR and qPCR products for the cell and gene therapy field. With a background in biochemistry and molecular biology research, she brings experience in analytical verification and clinical validation testing as well as research and development for new products in the cell and gene therapy space.

 

 

In association with

 

This webinar was recorded on 17 November 2023